Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2016, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2016-07-01
DOI
10.1155/2016/2138627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of circulating inflammatory factors in non-small cell lung cancer: A systematic review and meta-analysis
- (2017) Chen Liao et al. Cancer Biomarkers
- Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model
- (2016) Toshihiro Suzuki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Strategies in functional proteomics: Unveiling the pathways to precision oncology
- (2016) Rosy Favicchio et al. CANCER LETTERS
- Interleukin-22 receptor is overexpressed in nonsmall cell lung cancer and portends a poor prognosis
- (2016) Antoine Guillon et al. EUROPEAN RESPIRATORY JOURNAL
- Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer
- (2016) Guanqun Ge et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
- (2016) Elisabeth Quoix et al. LANCET ONCOLOGY
- Possible target-related proteins and signal network of bufalin in A549 cells suggested by both iTRAQ-based and label-free proteomic analysis
- (2016) Dong-Mei Zhang et al. PROTEOMICS
- Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis
- (2016) Liang Gong et al. Oncotarget
- Advances in mass spectrometry-based clinical biomarker discovery
- (2016) Christopher A. Crutchfield et al. Clinical Proteomics
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor-associated macrophages in cancers
- (2015) W. Hu et al. Clinical & Translational Oncology
- Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
- (2015) A. Patnaik et al. CLINICAL CANCER RESEARCH
- Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
- (2015) Reem M. Sallam DISEASE MARKERS
- A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
- (2015) G. Giaccone et al. EUROPEAN JOURNAL OF CANCER
- Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors
- (2015) LEI ZHAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Antibodies to watch in 2016
- (2015) Janice M. Reichert mAbs
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
- (2015) Ninh M. La-Beck et al. PHARMACOTHERAPY
- Quantitative proteomics using SILAC: Principles, applications, and developments
- (2015) Xiulan Chen et al. PROTEOMICS
- SILAC for biomarker discovery
- (2015) Gunnar Dittmar et al. Proteomics Clinical Applications
- Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer
- (2015) Edward B. Garon SEMINARS IN ONCOLOGY
- Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12
- (2015) Theofanis Floros et al. SEMINARS IN ONCOLOGY
- IL-6 polymorphism in non-small cell lung cancer: a prognostic value?
- (2015) Mónica Gomes et al. TUMOR BIOLOGY
- A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer
- (2015) Guang-He Fei et al. OncoTargets and Therapy
- Siltuximab (CNTO 328): a promising option for human malignancies
- (2015) Bao-An Chen et al. Drug Design Development and Therapy
- The Evolution of Therapies in Non-Small Cell Lung Cancer
- (2015) Vishal Boolell et al. Cancers
- Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer
- (2015) Bo Pan et al. Scientific Reports
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- (2014) Ho-June Lee et al. CANCER CELL
- A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors
- (2014) E. Angevin et al. CLINICAL CANCER RESEARCH
- Super-SILAC: current trends and future perspectives
- (2014) Anjana Shenoy et al. Expert Review of Proteomics
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women
- (2014) J. Lortet-Tieulent et al. LUNG CANCER
- Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer
- (2014) Min Wang et al. PLoS One
- Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches
- (2014) Wen Zhang et al. PROTEOMICS
- The Treg/Th17 Paradigm in Lung Cancer
- (2014) Min-Chao Duan et al. Journal of Immunology Research
- Proteomic biomarkers in lung cancer
- (2013) M. D. Pastor et al. Clinical & Translational Oncology
- Proteomic analysis of pleural effusion from lung adenocarcinoma patients by shotgun strategy
- (2013) Shu-hong Sheng et al. Clinical & Translational Oncology
- Cytokine effects on cell survival and death of A549 lung carcinoma cells
- (2013) Michalis Kastamoulas et al. CYTOKINE
- Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression
- (2013) Qingli Zeng et al. CYTOKINE
- Surgery decreases number of cells secreting cytotoxic mediators and increases secretion of interleukin 10 in patients with lung cancer
- (2013) P. Rybojad et al. EJSO
- Identification of proteomic signatures associated with lung cancer and COPD
- (2013) M.D. Pastor et al. Journal of Proteomics
- Loss of p53 Attenuates the Contribution of IL-6 Deletion on Suppressed Tumor Progression and Extended Survival in Kras-Driven Murine Lung Cancer
- (2013) Xiaohong Tan et al. PLoS One
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- The expanding field of SILAC
- (2012) Shao-En Ong ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
- (2012) M. A. Swartz et al. CANCER RESEARCH
- Development of transcriptomic biomarker signature in human saliva to detect lung cancer
- (2012) Lei Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
- (2012) Chin Hao Chang et al. INTERNATIONAL JOURNAL OF CANCER
- Proteomic Approaches to the Discovery of Cancer Biomarkers for Early Detection and Personalized Medicine
- (2012) Kazufumi Honda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Integrative Proteomics and Tissue Microarray Profiling Indicate the Association between Overexpressed Serum Proteins and Non-Small Cell Lung Cancer
- (2012) Yansheng Liu et al. PLoS One
- TG4010
- (2012) Jean-Marc Limacher et al. OncoImmunology
- Biomarkers for the lung cancer diagnosis and their advances in proteomics
- (2011) Hye-Jin Sung et al. BMB Reports
- Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
- (2011) Marina Lesina et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- VEGF and IL-18 in induced sputum of lung cancer patients
- (2011) Nikoletta Rovina et al. CYTOKINE
- Intra-individual variability over time in serum cytokine levels among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- (2011) Jonathan N. Hofmann et al. CYTOKINE
- Chemokines in tumor development and progression
- (2011) Naofumi Mukaida et al. EXPERIMENTAL CELL RESEARCH
- Active immunotherapy for non-small-cell lung cancer: moving toward a reality
- (2011) Cesar A Perez et al. Expert Review of Anticancer Therapy
- Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
- (2011) Sharon R. Pine et al. JNCI-Journal of the National Cancer Institute
- Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
- (2011) Elisabeth Quoix et al. LANCET ONCOLOGY
- Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry
- (2011) Hua Xiao et al. MOLECULAR & CELLULAR PROTEOMICS
- Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk
- (2011) Wen-jia Peng et al. MOLECULAR BIOLOGY REPORTS
- The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis
- (2011) Donna O'Dwyer et al. PLoS One
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Oncoproteomics
- (2010) S. Joshi et al. CLINICA CHIMICA ACTA
- IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines
- (2010) Li Zeng et al. CYTOKINE
- Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)
- (2010) C. Hontscha et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Lung cancer proteomics, clinical and technological considerations
- (2010) Janne Lehtiö et al. Journal of Proteomics
- A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer
- (2010) Rodryg Ramlau et al. Journal of Thoracic Oncology
- The Role of Inflammation in the Pathogenesis of Non-small Cell Lung Cancer
- (2010) Dermot S. O'Callaghan et al. Journal of Thoracic Oncology
- IL-37 is a fundamental inhibitor of innate immunity
- (2010) Marcel F Nold et al. NATURE IMMUNOLOGY
- A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants
- (2010) Luigi De Petris et al. Proteome Science
- Fighting cancers from within: augmenting tumor immunity with cytokine therapy
- (2010) Marc Pellegrini et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non-Small Cell Lung Cancer among Women
- (2009) A. L. Van Dyke et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy — Association of interleukin-8 and VEGF with survival
- (2009) Marika Crohns et al. CYTOKINE
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
- (2009) Lin Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research
- (2009) A. Punturieri et al. JNCI-Journal of the National Cancer Institute
- Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
- (2009) Marc Pellegrini et al. NATURE MEDICINE
- Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases
- (2008) Robert D. Gray et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Non-Smad pathways in TGF-β signaling
- (2008) Ying E Zhang CELL RESEARCH
- Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts
- (2008) W. Zhang et al. CLINICAL CANCER RESEARCH
- Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma
- (2008) W.-C. Liao et al. CLINICAL CANCER RESEARCH
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer
- (2007) Duygu Derin et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search